• Je něco špatně v tomto záznamu ?

A karyometric study on ageing and butyrate or imatinib treated human leukemic myeloblasts represented by K562 cells originated from chronic myeloid leukaemia

K. Smetana, H. Pilcova, M. Pluskalova, Z. Hrkal

. 2007 ; 54 (5) : 359-364.

Jazyk angličtina Země Slovensko

Perzistentní odkaz   https://www.medvik.cz/link/bmc10015025

The present study was undertaken to provide more information on nuclear diameter in leukemic granulocytic early precursors myeloblasts. These cells represented by K562 myeloblasts originated from the blastic phase of the chronic myeloid leukaemia (CML) carry characteristic bcr-abl fusion gene. They represent a convenient model for in vitro studies of CML myeloblasts and are sensitive to various agents which may induce ageing, differentiation and cell death. Mean nuclear diameter (MNuD) and largest nuclear diameter (Mx NuD) in stained cytospins of these cells were measured at a high light microscopic magnification by means of computer programme. Starving cultures were used for induction of ageing without preceding differentiation, sodium butyrate was used as a cytostatic agent or differentiation inducer and imatinib mesylate represented a cytostatic agent for CML. The largest shift of MNuD to smaller values was noted in ageing cultures or cultures treated with butyrate. The decrease of MNuD was less apparent in resistant cells treated with imatinib. This drug, however, produced a very large incidence of necrotic or apoptotic cells or bodies. From the methodical point of view it should be mentioned that values of maximal nuclear diameter (MxNuD) followed similar trends as MNuD and thus provided similar information. The measurement of both nuclear diameters, i.e. MNuD and MxNuD might be a complementary and simple tool to evaluate the cell state in cytological preparations because of their decrease in ageing cells or cells treated with antiproliferative drugs of different mode of action.

000      
03003naa 2200349 a 4500
001      
bmc10015025
003      
CZ-PrNML
005      
20120910175118.0
008      
100623s2007 xo e eng||
009      
AR
035    __
$a (PubMed)17688365
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xo
100    1_
$a Smetana, Karel, $d 1930- $7 nlk19990073860
245    12
$a A karyometric study on ageing and butyrate or imatinib treated human leukemic myeloblasts represented by K562 cells originated from chronic myeloid leukaemia / $c K. Smetana, H. Pilcova, M. Pluskalova, Z. Hrkal
314    __
$a Institute of Hematology and Blood Transfusion, U nemocnice 1, Praha 2, 128 20 Czech Republic karel.smetana@uhkt.cz
520    9_
$a The present study was undertaken to provide more information on nuclear diameter in leukemic granulocytic early precursors myeloblasts. These cells represented by K562 myeloblasts originated from the blastic phase of the chronic myeloid leukaemia (CML) carry characteristic bcr-abl fusion gene. They represent a convenient model for in vitro studies of CML myeloblasts and are sensitive to various agents which may induce ageing, differentiation and cell death. Mean nuclear diameter (MNuD) and largest nuclear diameter (Mx NuD) in stained cytospins of these cells were measured at a high light microscopic magnification by means of computer programme. Starving cultures were used for induction of ageing without preceding differentiation, sodium butyrate was used as a cytostatic agent or differentiation inducer and imatinib mesylate represented a cytostatic agent for CML. The largest shift of MNuD to smaller values was noted in ageing cultures or cultures treated with butyrate. The decrease of MNuD was less apparent in resistant cells treated with imatinib. This drug, however, produced a very large incidence of necrotic or apoptotic cells or bodies. From the methodical point of view it should be mentioned that values of maximal nuclear diameter (MxNuD) followed similar trends as MNuD and thus provided similar information. The measurement of both nuclear diameters, i.e. MNuD and MxNuD might be a complementary and simple tool to evaluate the cell state in cytological preparations because of their decrease in ageing cells or cells treated with antiproliferative drugs of different mode of action.
650    _2
$a stárnutí $x účinky léků $7 D000375
650    _2
$a butyráty $x farmakologie $7 D002087
650    _2
$a bcr-abl fúzní proteiny $x genetika $7 D016044
650    _2
$a lidé $7 D006801
650    _2
$a buňky K562 $7 D020014
650    _2
$a karyotypizace $7 D007621
650    _2
$a chronická myeloidní leukemie $x genetika $7 D015464
650    _2
$a piperaziny $x farmakologie $7 D010879
650    _2
$a pyrimidiny $x farmakologie $7 D011743
650    _2
$a financování organizované $7 D005381
700    1_
$a Pilcová, Hana. $7 _AN050486
700    1_
$a Pluskalová, Michaela $7 xx0115460
700    1_
$a Hrkal, Zbyněk, $d 1934- $7 xx0059987
773    0_
$t Neoplasma $w MED00003470 $g Roč. 54, č. 5 (2007), s. 359-364 $x 0028-2685
910    __
$a ABA008 $b A 1194 $y 8
990    __
$a 20100625150842 $b ABA008
991    __
$a 20120910175312 $b ABA008
999    __
$a ok $b bmc $g 750893 $s 614571
BAS    __
$a 3
BMC    __
$a 2007 $b 54 $c 5 $d 359-364 $i 0028-2685 $m Neoplasma $n Neoplasma $x MED00003470
LZP    __
$a 2010-B1/mkme

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...